Skip to main content
TipRanks
Go Ultimate75% OFF

BioCorRx (BICX) Stock Statistics & Valuation Metrics

6 Followers

Total Valuation

BioCorRx has a market cap or net worth of $6.28M. The enterprise value is $17.35M.

Market Cap
$6.28M
Enterprise Value
$17.35M

Share Statistics

BioCorRx has 29,758,177 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
29,758,177
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

BioCorRx’s return on equity (ROE) is 0.31 and return on invested capital (ROIC) is 112.37%.

Return on Equity (ROE)
0.31
Return on Assets (ROA)
-1.60
Return on Invested Capital (ROIC)
112.37%
Return on Capital Employed (ROCE)
0.78
Revenue Per Employee
265.75K
Profits Per Employee
-1.15M
Employee Count
3
Asset Turnover
0.37
Inventory Turnover
0.74

Valuation Ratios

The current PE Ratio of BioCorRx is -4.43. BioCorRx’s PEG ratio is -0.02.

PE Ratio
-4.43
PS Ratio
56.09
PB Ratio
-0.48
Price to FCF
-3.28
Price to Operating Cash Flow
-3.31
PEG Ratio
-0.02

Income Statement

In the last 12 months, BioCorRx had revenue of 797.24K and earned -3.44M in profits. Earnings per share was -0.19.

Revenue
797.24K
Gross Profit
691.38K
Operating Income
-4.83M
Pretax Income
-3.51M
Net Income
-3.44M
EBITDA
-2.60M
Earnings Per Share (EPS)
-0.19

Cash Flow

In the last 12 months, operating cash flow was -1.90M and capital expenditures 3, giving a free cash flow of -1.90M billion.

Operating Cash Flow
-1.90M
Free Cash Flow
-1.90M
Free Cash Flow per Share
-0.06

Dividends & Yields

BioCorRx pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-30.51%
Earnings Yield
-32.39%

Stock Price Statistics

Beta
-0.03
52-Week Price Change
-53.35%
50-Day Moving Average
0.22
200-Day Moving Average
0.30
Relative Strength Index (RSI)
47.93
Average Volume (3m)
2,897

Important Dates

BioCorRx upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
Aug 17, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

BioCorRx as a current ratio of 0.10, with Debt / Equity ratio of -18.97%

Current Ratio
0.10
Quick Ratio
0.08
Debt to Market Cap
0.37
Net Debt to EBITDA
-0.76
Interest Coverage Ratio
-5.61

Taxes

In the past 12 months, BioCorRx has paid -68.62K in taxes.

Income Tax
-68.62K
Effective Tax Rate
0.02

Enterprise Valuation

BioCorRx EV to EBITDA ratio is -2.27, with an EV/FCF ratio of -4.48.

EV to Sales
76.62
EV to EBITDA
-2.27
EV to Free Cash Flow
-4.48
EV to Operating Cash Flow
-4.48

Balance Sheet

BioCorRx has $18.23K in cash and marketable securities with $2.30M in debt, giving a net cash position of -$2.28M billion.

Cash & Marketable Securities
$18.23K
Total Debt
$2.30M
Net Cash
-$2.28M
Net Cash Per Share
-$0.08
Tangible Book Value Per Share
-$0.47

Margins

Gross margin is 248.52%, with operating margin of -3915.67%, and net profit margin of -1837.63%.

Gross Margin
248.52%
Operating Margin
-3915.67%
Pretax Margin
-2830.85%
Net Profit Margin
-1837.63%
EBITDA Margin
-3375.14%
EBIT Margin
-2430.28%

Scores

Smart Score
―
AI Score
43